A comparison of 1-month and 6-month clopidogrel therapy on clinical and angiographic outcome after stent implantation

Heart and Vessels

Volumn 18, Issue 3, 2003, Pages 123-129

  Pekdemir, Hasan ^a   Cin, Veli Gokhan ^a   Camsari, Ahmet ^a   Cicek, Dilek ^a   Akkus, Mehmet Necdet ^a   Doven, Oben ^a   Parmaksiz, Tuncay ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Clopidogrel; In stent restenosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; CORASPIN; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIQUEMINE; NITRATE; TIROFIBAN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FOLLOW UP; HEALTH STATUS; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SCORING SYSTEM; SHORT COURSE THERAPY; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

AGED; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; STENTS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0043064103     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-003-0704-1     Document Type: Article

References (37)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, et al., for the Benestent Study Group (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489-495
2. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, et al., for the Stent Restenosis Study Investigators (1994) A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331:496-501
3. Matsumura A, Hashimoto Y, Numano F (2000) Influence of stent design on the immediate and long-term outcome after coronary stent implantation: a comparison of sinusoidal-ring and tube stents. Heart Vessels 15:221-226
4. Lubbe DF, Holmes DR (2001) Prevention of restenosis after percutaneous coronary interventions. ACC Curr J Rev Jan/Feb: 39-42
5. Chandrasekar B, Tanguay JF (2000) Platelets and restenosis. J Am Coll Cardiol 35:555-562
6. Mehta SR, Yusuf S, Peters RJG, et al (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358:527-533
7. Bhatt DL, Bertrand ME, Berger PB, L'Allier PL, Moussa I, Moses JW, Dangas G, Taniuchi M, Lasala JM, Holmes DR, Ellis SG, Topol EJ (2002) Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol 39:9-14
8. Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334:1084-1089
9. Bertrand ME, Legrand V, Boland J, et al. (1998) Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: the Full Anticoagulation Versus Aspirin and Ticlopidine (FANTASTIC) study. Circulation 98:1597-603
10. Urban P, Macaya C, Rupprecht HJ, et al., for the MATTIS Investigators (1998) Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients. Circulation 98:2126-2132
11. CAPRIE Steering Committee (1996) A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk for ischemic events (CAPRIE). Lancet 348:1329-1339
12. The CURE Investigators (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes witouth ST-segment elevation. N Engl Med 345:494-502
13. Reimers B, Moussa I, Akiyama T, Tucci G, Ferraro M, Martini G, Blengino S, Di Mario C, Colombo A (1997) Long-term clinical follow-up after successful repeat percutaneous intervention for stent restenosis. J Am Coll Cardiol 30:186-192
14. Anderson HV, McNatt J, Clubb FJ, Herman M, Maffrand JP, DeClerck F, Ahn C, Buja LM, Willerson JT (2001) Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic atherosclerotic canine coronary arteries. Circulation 104:2331-2337
15. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA (1989) Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci USA 86:8412-8416
16. Le Breton H, Plow EF, Topol EJ. Role of platelets in restenosis after percutaneous coronary revascularization. J Am Coll Cardiol 1996;28:1643-1651
17. Crowley ST, Dempsey EC, Horwitz KB, et al. (1994) Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate. Circulation 90:1908-1918
18. Pakala R, Willerson JT, Benedict CR (1997) Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation. Circulation 96:2280-2286
19. Coukell AJ, Markham A (1997) Clopidogrel. Drugs 54:745-750
20. Savi P, Herbert JM (1996) ADP receptors on platelets and ADP selective antiaggregating agents. Med Res Rev 16:159-179
21. Boneu B, Destelle G (1996) Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients. Thromb Haemost 76:939-943
22. Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH (2000) Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting. The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS). Circulation 102:624-629
23. Schühlen H, Kastrati A, Pache J, Dirschinger J, Schomig A (2001) Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5678 patients with a four-week ticlopidine regimen. J Am Coll Cardiol 37:2066-2073
24. Kornowski R, Mintz GS, Kent KM, et al. (1997) Increased restenosis in diabetes mellitus after coronary interventions is due to exaggreated intimal hyperplasia: a serial intravascular ultrasound study. Circulation 95:1366-1369
25. Schühlen H, Kastrati A, Dirschinger J, et al. (1998) Intracoronary stenting and risk for major adverse cardiac events during the first month. Circulation 98:104-111
26. Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A (1997) Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 29:6-12
27. Claver AL, Dawkins KD, Gray HH, et al. (1998) Intracoronary multi-link stents: experience in 218 patients using aspirin alone. Heart 80:499-504
28. Elezi S, Kastrati A, Neumann FJ, et al. (1998) Vessel size and longterm outcome after coronary stent placement. Circulation 98:1875-1880
29. Akiyama T, Moussa I, Reimers B, Ferraro M, Kobayashi Y, Blengino S, Di Francesco L, Finci L, Di Mario C, Colombo A (1998) Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. J Am Coll Cardiol 32:1610-1617
30. Strauss BH, Serruys PW, de Scheerder IK, et al. (1991) Relative risk analysis of angiographic predictors of restenosis within the coronary wall-stent. Circulation 84:1636-1643
31. Hayashida K, Tanaka M, Morita H, Hayashi F, Inada T, Suzuki H, Sakamoto T, Katsuragawa M, Hibino H, Kambara H (2002) Chlamydia pneumoniae seropositivity predicts the risk of restenosis after percutaneous transluminal coronary angioplasty. Heart Vessels 16:137-145
32. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288:2411-2420
33. Bhatt DL, Hirsch AT, Chew DP, Ringleb P, Hacke W, Topol EJ (2001) Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation 103:363-368
34. Waksman R, Ajani AE, White RL, et al. (2001) Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients within-stent restenosis washington radiation for in-stent restenosis trial plus 6 months of clopidogrel (WRIST PLUS). Circulation 103:2332-2335
35. Post MJ, Borst C, Kuntz RE (1994) The relative importance of arterial remodelling compared with intimal hyperplasia in lumen narrowing after balloon angioplasty. Circulation 89:2816-2821
36. Markovitz JH, Roubin GS, Parks JM, Bittner V (1996) Platelet activation and restenosis after coronary stenting: flow cytometric detection of wound-induced platelet activation. Coron Artery Dis 7:657-665
37. Lowe HC, Oesterle SN, Khachigian LM (2002) Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 39:183-193